D-0010-2018 Class II Terminated

Recalled by Unichem Pharmaceuticals Usa Inc — Hasbrouck Heights, NJ

FDA drug recall D-0010-2018 was initiated by Unichem Pharmaceuticals Usa Inc on Oct 2, 2017 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was observed during the 18 month stability testing. The recall status is terminated (terminated Sep 13, 2018). Affected quantity: 96,876 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 25, 2017
Initiation Date
Oct 2, 2017
Termination Date
Sep 13, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
96,876 bottles

Product description

Bisoprolol Fumarate tablets, 5 mg, 30-count bottles, Rx only, Manufactured by: UNICHEM LABORATORIES, LTD. Pilerne Ind. Estate, Pilerne, Bardez, Goa, 403 511, India, Marketed by: UNICHEM PHARMACEUTICALS, (USA), INC. Hasbrouck Heights, NJ 07604, NDC 29300-126-13.

Reason for recall

Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was observed during the 18 month stability testing.

Distribution pattern

Product was distributed nationwide

Code information

Lot #: GBOL16001, GBOL16002, Exp 12/31/2017; GBOL16015, Exp 03/31/2018.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0010-2018
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0010-2018. Report a data issue: hello@regdatalab.com.